FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Vasocon patents



      
           
This page is updated frequently with new Vasocon-related patent applications. Subscribe to the Vasocon RSS feed to automatically get the update: related Vasocon RSS feeds. RSS updates for this page: Vasocon RSS RSS


Date/App# patent app List of recent Vasocon-related patents
05/29/14
20140148460
Therapeutic compositions
The invention relates to a product containing the compound of formula (i) below (i) or a pharmaceutically acceptable salt of this compound, in combination with at least one compound having pde5-inhibitory properties, or a pharmaceutically acceptable salt thereof, for therapeutic use, simultaneously, separately or over a period of time, in the treatment of a disease wherein vasoconstriction is involved.. .
03/13/14
20140073590
 Methods for treating pulmonary hypertension patent thumbnailMethods for treating pulmonary hypertension
The present invention relates to methods for treating or preventing pulmonary hypertension, reducing mortality in a subject experiencing pulmonary hypertension, or inhibiting adp-mediated vasoconstriction of pulmonary arteries in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition comprising a reversible p2y12 receptor antagonist. Also provided are related medicaments, pharmaceutical compositions, and methods for preparing the medicaments..
12/05/13
20130324866
 Indications of cross-section of small branched blood vessels patent thumbnailIndications of cross-section of small branched blood vessels
Systems and methods of extracting information relating to diameter and/or diameter changes in small blood vessels such as arterioles. This information may be used to assess a degree of vasoconstriction and/or vasodilatation.
12/05/13
20130324475
 Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation patent thumbnailArthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
A method and solution for perioperatively inhibiting a variety of pain and inflammation processes during arthroscopic procedures. The solution preferably includes a vasoconstrictor that exhibits alpha-adrenergic activity and one or more additional pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated ringer's solution.
11/14/13
20130304328
 Ttg for body cooling and driver alertness patent thumbnailTtg for body cooling and driver alertness
A system for keeping a driver alert by employing a thermal grill that includes warm and cool regions. The disclosed system includes an alert module that configures the thermal grill to a heat sink configuration and a heat source configuration.
10/31/13
20130289470
 Kit for the treatment of envenomation patent thumbnailKit for the treatment of envenomation
A kit for the treatment of envenomation, includes: a syringe with needle, filled with a liquid for local anaesthesia and vasoconstriction, a bistoury having a blade with an incision depth limiter, and a syringe with needle, filled with a washing liquid including the same compounds as those of the syringe with the liquid for local anaesthesia and vasoconstriction, but at a lower concentration. Such a kit permits local emergency extraction of the venom from a bite or sting inoculated by a venomous animal..
10/31/13
20130288999
 Compositions and methods for modulation of vascular structure and/or function patent thumbnailCompositions and methods for modulation of vascular structure and/or function
The present invention relates to compositions comprising semi-crystalline β-1-4-n-acetylglucosamine polymers (p-glcnac) and methods utilizing such polymers modulation of vascular structure and/or function. The compositions and methods disclosed are useful for stimulating, in a p-glcnac concentration-dependent manner, endothelin-1 release, vasoconstriction, and/or reduction in blood flow out of a breached vessel, as well as for contributing to or effecting cessation of bleeding.
10/24/13
20130281485
 Bridged bicyclic rho kinase inhibitor compounds, compositions and use patent thumbnailBridged bicyclic rho kinase inhibitor compounds, compositions and use
The present invention is directed to synthetic bridged bicyclic compounds that are inhibitors of rho-associated protein kinase. The present invention is also directed to pharmaceutical compositions comprising such compounds and a pharmaceutically acceptable carrier.
10/17/13
20130274245
 Composition for prevention of vasoactivity in the treatment of blood loss and anemia patent thumbnailComposition for prevention of vasoactivity in the treatment of blood loss and anemia
The present invention relates to the prevention of cardiovascular and central nervous system side effects in mammals who receive transfusions of hemoglobin based oxygen carriers (hboc) or stored blood products containing a concentration of hemoglobin sufficient to induce vasoconstriction, by adding a vasoactivity reducing effective amount of one or more phosphodiesterase inhibitors in combination with a calcium channel blocker and/or an alpha agonist, to the circulation, or alternatively to the hboc or stored blood, thereby preventing the manifestation of vasoactivity attributable to the presence of free tetrameric hemoglobin (hb).. .
10/17/13
20130269829
 Aluminium cylinder for no/nitrogen gas mixture and use thereof in the treatment of pulmonary vasoconstrictions patent thumbnailAluminium cylinder for no/nitrogen gas mixture and use thereof in the treatment of pulmonary vasoconstrictions
The invention relates to a container for packaging no/n2 mixtures, such as a gas cylinder, comprising a main body (1) comprising an internal volume (7) having a capacity between 2 and 30 liters and containing an no/n2 mixture at a pressure above atmospheric pressure, the main body (1) being formed from an aluminum alloy, characterized in that the main body (1) is formed from an aluminum alloy comprising aluminum and a proportion by weight of cr of between 0.05 and 0.80%, of cu of between 1 and 3%, of pb of at most 100 ppm, of zn of between 5 and 8%, and of mg of between 1 and 3%.. .
10/10/13
20130267500
5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
Uses of 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of an individual's norepinephrine level, wherein said disorders include but are not limited to hypernorepinephrinemia, cardiomyopathy, cardiac hypertrophy, cardiomyocyte hypertrophy in post-myocardial infarction remodeling, elevated heart rate, vasoconstriction, acute pulmonary vasoconstriction, hypertension, heart failure, cardiac dysfunction after stroke, cardiac arrhythmia, metabolic syndrome, abnormal lipid metabolism, hyperthermia, cushing syndrome, pheochromocytoma, epilepsy, obstructive sleep apnea, insomnia, glaucoma, osteoarthritis, rheumatoid arthritis, and asthma.. .
09/19/13
20130245538
Control of blood vessel physiology to treat skin disorders
In a method for treating an affected skin region of a patient having a skin disorder, a vasodilation composition is applied to an affected skin region of a patient, the affected skin region exhibiting a skin disorder characterized by at least one abnormal blood vessel, and the affected skin region is then treated so as to non-invasively disrupt tissue architecture, e.g., by inducing ischemia, of the at least one abnormal blood vessel. A vasoconstriction composition can then be applied to the skin region to cause vasoconstriction of the at least one blood vessel in order to promote healing..
08/29/13
20130219829
Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition and the use thereof
A highly purified and heat stable cross-linked tetrameric hemoglobin suitable for use in mammals without causing renal injury and vasoconstriction is provided. A high temperature and short time (htst) heat processing step is performed to remove undesired dimeric form of hemoglobin and the plasma proteins impurities effectively.
08/22/13
20130217714
Non-flushing niacin analogues, and methods of use thereof
One aspect of the present invention relates to substituted pyridines and pharmaceutically acceptable salts thereof that are active against a range of mammalian maladies. Another aspect of the invention relates to a pharmaceutical composition, comprising a compound of the present invention or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable excipient.
07/04/13
20130172324
Method for treating cardiovascular diseases using rho kinase inhibitor compounds
This invention is directed to methods of preventing or treating diseases or conditions associated with excessive cell proliferation, remodeling, inflammation, and vasoconstriction. Particularly, this invention is directed to methods of treating cardiovascular diseases or conditions such as stent restenosis and thrombosis, vascular thrombosis, cerebral vasospasm, atherosclerosis, systemic hypertension, cardiac hypertrophy, and sexual dysfunction.
04/25/13
20130102859
System and method for detecting symptoms of hypoglycemia
An improved system and method for detecting a hypoglycemic event of a diabetic individual is provided. The system of the invention includes at least three sensors for monitoring the respective physiological parameter selected from the following list: heart rate, motorial activity, respiring rate, vasoconstriction, temperature of the skin and galvanic resistance of the skin of the user.
02/28/13
20130052251
Composition and method for treating nosebleeds
A composition and method for treating nosebleed, that is, epistaxis. The composition comprises bismuth subgallate and a vasoconstriction agent, preferably oxymetazoline.
02/28/13
20130052232
Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking
Methods for preparation of a heat stable hemoglobin based oxygen-carrier-containing pharmaceutical composition such that beta-beta cross-linking is favored are provided. Using the methods of the present invention, the oxygen affinity of the resultant molecule can be controlled so that hemoglobin based oxygen carriers tailored for specific applications can be produced.
01/03/13
20130005756
Method for treating pulmonary diseases using rho kinase inhibitor compounds
This invention is directed to methods of preventing or treating diseases or conditions of the lungs associated with excessive cell proliferation, remodeling, inflammation, vasoconstriction, bronchoconstriction, airway hyperreactivity and edema. Particularly, this invention is directed to methods of treating pulmonary diseases such as asthma; chronic obstructive pulmonary disease; respiratory tract illness caused by respiratory syncytial virus; pulmonary arterial hypertension; acute respiratory distress syndrome and ventilator induced lung injury; cystic fibrosis; bronchiectasis; alpha-1-antitrypsin deficiency; rhinitis; rhinosinusitis; primary ciliary dyskinesia; pneumonia; bronchiolitis caused by agents other than respiratory syncytial virus; and interstitial lung disease including lymphangioleiomyomatosis; idiopathic pulmonary fibrosis; obliterative bronchiolitis or bronchiolitis obliterans organizing pneumonia due to lung transplantation or hsct; nonspecific interstitial pneumonia; cryptogenic organizing pneumonia; acute interstitial pneumonia; respiratory bronchiolitis-associated interstitial lung disease; or pulmonary sarcoidosis.
01/03/13
20130005734
Therapeutic compositions
The invention relates to a product containing the compound of formula (i) below (i) or a pharmaceutically acceptable salt of this compound, in combination with at least one compound having pde5-inhibitory properties, or a pharmaceutically acceptable salt thereof, for therapeutic use, simultaneously, separately or over a period of time, in the treatment of a disease wherein vasoconstriction is involved.. .
01/03/13
20130000638
Aluminum cylinder for no/nitrogen gas mixture and use thereof in the treatment of pulmonary vasoconstrictions
The invention relates to a container for packaging no/n2 mixtures, such as a gas cylinder, comprising a main body (1) comprising an internal volume (7) having a capacity between 2 and 30 liters and containing an no/n2 mixture at a pressure above atmospheric pressure, the main body (1) being formed from an aluminum alloy, characterized in that the main body (1) is formed from an aluminum alloy comprising aluminum and a proportion by weight of cr of between 0.05 and 0.80%, of cu of between 1 and 3%, of pb of at most 100 ppm, of zn of between 5 and 8%, and of mg of between 1 and 3%.. .


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Vasocon for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Vasocon with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



1.7513

1089

10 - 0 - 21